Lv616
2316 积分 2022-04-14 加入
Mismatch repair deficiency/microsatellite instability (dMMR/MSI-H) in rectal cancer patients treated with standard neoadjuvant therapy: a systematic review and meta-analysis
6天前
已完结
Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard?
10天前
已完结
Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm
11天前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
12天前
已完结
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
12天前
已完结
Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire
17天前
已完结
Early-Onset Gastrointestinal Cancers
17天前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
21天前
已完结
The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma
28天前
已完结
A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis
28天前
已完结
皖公网安备34019202002308
